Jefferies analyst Shaunak Deepak weighed in with his opinions on MannKind Corporation (NASDAQ:MNKD), following positive feedback from physicians from the American Diabetes Association on the Diabetes …
MannKind Corporation (NASDAQ:MNKD) shares increased more than 2% in pre-market trading to $6.25 after Shaunak Deepak, an analyst at Jefferies, reiterated a Buy …
By Sarah Roden Analysts have differing views regarding how Micron Technology, Inc. (NASDAQ: MU) will be impacted by the decline of personal computing.
In a research report released today, Jefferies analyst Shaunak Deepak initiated coverage on shares of MannKind (NASDAQ:MNKD) with a Buy rating and a $10 price target, …
